Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163672 | SCV000214244 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000471256 | SCV000557583 | likely benign | Familial adenomatous polyposis 2 | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000163672 | SCV000685554 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697155 | SCV000722562 | likely benign | not provided | 2021-05-24 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000471256 | SCV004843495 | likely benign | Familial adenomatous polyposis 2 | 2023-10-27 | criteria provided, single submitter | clinical testing |